TY - JOUR
T1 - Comparative outcomes of younger and older hospitalized patients with inflammatory bowel disease treated with corticosteroids
AU - Weber, Nicholas K.
AU - Bruining, David H.
AU - Loftus, Edward V.
AU - Tremaine, William J.
AU - Augustin, Jessica J.
AU - Becker, Brenda D.
AU - Kammer, Patricia P.
AU - Harmsen, William Scott
AU - Zinsmeister, Alan R.
AU - Pardi, Darrell S.
PY - 2013/11
Y1 - 2013/11
N2 - Background: Data on the differences in inpatient treatment approaches and outcomes between younger and older patients with inflammatory bowel disease (IBD) are limited. Therefore, we used a parallel cohort study design to compare outcomes between younger and older patients with IBD. Methods: All anti-tumor necrosis factor (TNF)-naive patients aged 60 years and older hospitalized at our institution between 2003 and 2011 and treated with corticosteroids for an IBD flare were matched 1:1 to younger patients aged 18 to 50 years. Rates of corticosteroid response, colectomy, and initiation of anti-TNF therapy were compared. Results: Sixty-five patients were identified in each cohort. Median ages were 70 years (range, 60-94) and 30 years (range, 18-50) for the older and younger groups, respectively. Twenty-three percent of older patients were refractory to corticosteroids compared with 38% of the younger cohort (odds ratio, 0.5; 95% confidence intervals, 0.2-1.1). Older corticosteroid-refractory patients had surgery (80% versus 72%) and were started on anti-TNF therapy (20% versus 12%; P = 0.71), at a similar frequency as younger patients. Older steroid-responsive patients were less likely to start an anti-TNF agent during the first year of follow-up than younger patients (7% versus 31%, P = 0.006), but there was no difference in 1-year colectomy rates (27% versus 28%, P = 0.63). Conclusions: Corticosteroid response was similar in older and younger patients hospitalized for IBD. Inpatient treatment for corticosteroid-refractory patients was similar between cohorts. Older corticosteroid-responsive patients were less likely to be treated with an anti-TNF than younger patients.
AB - Background: Data on the differences in inpatient treatment approaches and outcomes between younger and older patients with inflammatory bowel disease (IBD) are limited. Therefore, we used a parallel cohort study design to compare outcomes between younger and older patients with IBD. Methods: All anti-tumor necrosis factor (TNF)-naive patients aged 60 years and older hospitalized at our institution between 2003 and 2011 and treated with corticosteroids for an IBD flare were matched 1:1 to younger patients aged 18 to 50 years. Rates of corticosteroid response, colectomy, and initiation of anti-TNF therapy were compared. Results: Sixty-five patients were identified in each cohort. Median ages were 70 years (range, 60-94) and 30 years (range, 18-50) for the older and younger groups, respectively. Twenty-three percent of older patients were refractory to corticosteroids compared with 38% of the younger cohort (odds ratio, 0.5; 95% confidence intervals, 0.2-1.1). Older corticosteroid-refractory patients had surgery (80% versus 72%) and were started on anti-TNF therapy (20% versus 12%; P = 0.71), at a similar frequency as younger patients. Older steroid-responsive patients were less likely to start an anti-TNF agent during the first year of follow-up than younger patients (7% versus 31%, P = 0.006), but there was no difference in 1-year colectomy rates (27% versus 28%, P = 0.63). Conclusions: Corticosteroid response was similar in older and younger patients hospitalized for IBD. Inpatient treatment for corticosteroid-refractory patients was similar between cohorts. Older corticosteroid-responsive patients were less likely to be treated with an anti-TNF than younger patients.
KW - Corticosteroids
KW - Crohn's disease
KW - Elderly
KW - Hospitalized
KW - Inflammatory bowel disease
KW - Older
KW - Outcomes
KW - Ulcerative colitis
KW - Younger
UR - http://www.scopus.com/inward/record.url?scp=84888321975&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84888321975&partnerID=8YFLogxK
U2 - 10.1097/01.MIB.0000436961.08029.17
DO - 10.1097/01.MIB.0000436961.08029.17
M3 - Article
C2 - 24105393
AN - SCOPUS:84888321975
SN - 1078-0998
VL - 19
SP - 2644
EP - 2651
JO - Inflammatory bowel diseases
JF - Inflammatory bowel diseases
IS - 12
ER -